LINK: Microsoft Teams

OBJECTIVES: Upon completion of this activity, the participant should be able to:  (1) Describe the rationale and evidence for routine comprehensive autoantibody testing in all patients with newly identified ILD  (2) Describe methods of autoantibody detection used commonly for evaluation of rheumatologic disease  (3) Identify high-risk autoantibodies associated with ILD development and progression, and explain how their presence influences screening frequency and clinical management.

FACULTY DISCLOSURE: Samera Vaseer, M.D. has no relevant financial relationship(s) with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

PLANNER DISCLOSURE: Susan Mathai, MD, is a consultant/researcher for Boehringer Ingelheim, and a researcher for United Therapeutics, Vicore Pharma, Cumberland Pharamceuticals, Atyr Pharam, and was an adviser for Verona, Pharma.  Adam Hayek, DO, is a researcher for Synairgen and was a researcher for Foresee Pharmaceuticals, Co., Ltd, Jansen-Sirukumab, Mesoblast Inc., Regeneron, and Kinevant Sciences GmbHand.  Ginger Tsai-Nguyen, MD, planner has no relevant financial relationship(s) with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships have been mitigated.

PLANNER DISCLOSURE: The planners have no relevant financial relationship(s) with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC:  Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For information, please contact Cynthia Hernandez at [email protected]